English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

These were the famous words of Edith Lincoln – a pioneer in the field of pediatric tuberculosis (TB) – who originally observed the natural history of tubercular infection and disease in children, about half a century ago [1]. Today, millions of children are exposed to adult tuberculosis which reports an alarming trend of multidrug-resistant (MDR: resistant to at least rifampicin and isoniazid) and extensively drug-resistant (XDR: additionally resistant to a fluoroquinolone and kanamycin/amikacin/capreomycin) strains. The threat of drug resistance in children has become a reality with the WHO global report 2013 [2] stating that a child with TB is as likely as an adult with TB to have MDR-TB. It is estimated that anywhere between 10000 and 20000 children in India might be acquiring MDR-TB every year [3].

Know TB to No TB: IAP presidential action plan 2014